The relationship between mean platelet volume and fasting plasma glucose differs with glucose tolerance status in a Korean general population: Gender differences

Platelets

Volumn 24, Issue 6, 2013, Pages 469-473

  Kim, Jin Hwa ^a   Kang, Seung Bum ^a   Kang, Ji In ^a   Kim, Jin Woo ^a   Kim, Sang Yong ^a   Bae, Hak Yeon ^a  

^a Chosun University   (South Korea)

Author keywords

Fasting plasma glucose; Glucose tolerance status; Mean platelet volume

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETES MELLITUS; FASTING PLASMA GLUCOSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEAN PLATELET VOLUME; MEDICAL EXAMINATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOUTH KOREA; THROMBOCYTE VOLUME;

EID: 84880899773     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2012.715214     Document Type: Article

References (26)

1. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993;328:1676-1685.
2. Allessandrini P, Me Rae J, Feman S, Fitzgerald GA. Thromboxane biosynthesis and platelet function in type 1 diabetes mellitus. N Engl J Med 1988;319:208-212.
3. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammatioñ Curr Pharm Des 2011;17:47-58.
4. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004;15:475-478.
5. Coban E, Kucuktag S, Basyigit S. Platelet activation in subjects with impaired glucose tolerance. Platelets 2007;18:591-594.
6. Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 2006;17:67-69.
7. Unübol M, Ayhan M, Güney E. The relationship between mean platelet volume with microalbuminuria and glycemic control in patients with type II diabetes mellitus. Platelets 2011 Nov 29. 2012;23:475-480.
8. Tavil Y, Sen N, Yazici H, Turfan M, Hizal F, Cengel A, Abaci A. Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients. Platelets 2010;21:368-372.
9. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 2012;35(suppl 1):S11-63.
10. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-444.
11. Brand FN, Abbott RD, Kannel WB. Diabetes, intermittent claudication, and risk of cardiovascular events. Diabetes 1989;38:504-509.
12. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991;338:1409-1411.
13. Bath P, Algert C, Chapman N, Neal B; PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004;35:622-626.
14. Pathansali R, Smith N, Bath P. Altered megakaryocyte-platelet haemostatic axis in hypercholesterolemia. Platelets 2001;12:292-297.
15. Shin WY, Jung DH, Shim JY, Lee HR. The association between non-alcoholic hepatic steatosis and mean platelet volume in an obese Korean population. Platelets 2011;22:442-446.
16. Park BJ, Shim JY, Lee HR, Jung DH, Lee JH, Lee YJ. The relationship of platelet count, mean platelet volume with metabolic syndrome according to the criteria of the American Association of Clinical Endocrinologists: A focus on gender differences. Platelets 2012;23:45-50.
17. Angiolillo DJ, Bernardo E, Sabaté M, Jimenez-Quevedo P, Costa MA, Palazuelos J, Hernández-Antolin R, Moreno R, Escaned J, Alfonso F, et al. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2007;50:1541-1547.
18. Shah B, Sha D, Xie D, Mohler III ER, Berger JS. The relationship between diabetes mellitus, metabolic syndrome, and platelet activity as measured by mean platelet volume: The National Health and Nutrition Examination Survey, 1999-2004. Diabetes Care 2012 Mar 12 2012;35:1074-1078.
19. Martyn CN, Matthews DM, Popp-Snijders C, Tucker J, Ewing DJ, Clarke BF. Effects of sorbinil treatment on erythrocytes and platelets of persons with diabetes. Diabetes Care 1986;9:36-39.
20. Taniguchi A, Fukushima M, Seino Y, Sakai M, Yoshii S, Nagasaka S, Yamauchi I, Okumura T, Nin K, Tokuyama K, et al. Platelet count is independently associated with insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism 2003;52:1246-1249.
21. Watanabe Y, Kawada M, Kobayashi B. Effect of insulin on murine megakaryocytopoiesis in a liquid culture system. Cell Struct Funct 1987;12:311-316.
22. Guthikonda S, Alviar CL, Vaduganathan M, Arikan M, Tellez A, DeLao T, Granada JF, Dong JF, Kleiman NS, Lev EI. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 2008;52:743-749.
23. Otahbachi M, Simoni J, Simoni G, Moeller JF, Cevik C, Meyerrose GE, Roongsritong C. Gender differences in platelet aggregation in healthy individuals. J Thromb Thrombolysis 2010;30:184-191.
24. Becker DM, Segal J, Vaidya D, Yanek LR, Herrera-Galeano E, Bray PF, Moy TF, Becker LC, Faraday N. Sex difference in platelet reactivity and response to low-dose aspirin therapy. JAMA 2006;295:1420-1427.
25. Brummitt DR, Barker HF. The determination of a reference range for new platelet parameters produced by the Bayer ADVIA120 full blood count analyser. Clin Lab Haematol 2000;22:103-107.
26. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002;117:399-404. Hospital(2012)